Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin

Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin

Transarterial chemoembolization using doxorubicin (TACE-DOX) is an effective therapy for advanced hepatocellular carcinoma (HCC). However, there are limited options for patients with TACE refractoriness. We compared the effectiveness between sorafenib and transarterial chemolipiodolization using epi...

Full description

Bibliographic Details
Main Authors: Sun Hong Yoo MD, PhD, Jung Hyun Kwon MD, PhD, Soon Woo Nam MD, PhD, Jong Yul Lee MD, Young Woon Kim MD, Dong Jae Shim MD, Sung Won Lee MD, Jeong Won Jang MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-06-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820935843

Internet

https://doi.org/10.1177/1073274820935843

Similar Items